Open Government Portal

Found 10 records similar to Testing devices for COVID-19: Serological testing devices

Federal

The purpose of this document is to provide guidance to manufacturers of serological assays intended for the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19 disease. The guidance outlines recommendations regarding the minimum testing that should be performed for SARS-CoV-2 diagnostics.

Last Updated: May 11, 2020
Date Published: Apr. 24, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19 pandemic, Antibody tests, serological assays.
Federal

We present the most up-to-date data on SARS-CoV-2 antibody timelines, including the longevity of antibodies, and the production and detection of neutralizing antibodies and provide practical guidance for clinical microbiology laboratories to both verify commercial serology assays and choose appropriate testing algorithms for their local populations.

Last Updated: May 28, 2021
Date Published: Apr. 29, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  CCDR, Canada Communicable Disease Report, COVID-19, SARS-CoV-2, coronavirus, pandemic, Canada, serological testing, serology algorithms
Federal

Testing for the virus, testing accuracy depends on when you get tested, and testing for antibodies.

Last Updated: Oct. 22, 2020
Date Published: Aug. 7, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, Coronavirus, testing, positive test, true positive, false positive, negative test, true negative, false negative
Federal

Nucleic acid-based testing is also called molecular testing, and is often called PCR. Molecular tests detect the virus genetic material (nucleic acids). Public health laboratories in Canada and around the world use nucleic acid-based testing to diagnose COVID-19 infection. This test is the gold standard to diagnose active COVID-19 infection in patients with symptoms.

Last Updated: Jun. 29, 2021
Date Published: Jun. 3, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, testing devices, testing devices for COVID-19, nucleic acid testing devices, molecular testing, PCR, nucleic acid-based testing, COVID-19 infection
Federal

A near patient in vitro diagnostic device (IVDD) is used for: point-of-care testing in a health care setting (for example, doctor’s office, pharmacy, at the bedside) or self-testing ( for example, used by individuals at home). Typically, these rapid test devices are simple to use and provide visual or simple results within a short time.

Last Updated: Jun. 29, 2021
Date Published: Jun. 3, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, testing devices, testing devices for COVID-19, point-of-care and self-testing devices, rapid tests
Federal

As the pandemic evolves, we are continuously updating our guidance and positions in light of the new scientific information available to us. We are open to reviewing all testing solutions as they become available.

Last Updated: Jun. 29, 2021
Date Published: May 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, testing devices, testing devices for COVID-19, testing solutions
Federal

The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices.

Last Updated: Nov. 4, 2020
Date Published: Sep. 29, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, testing devices, antigen testing devices, minimum values of sensitivity for COVID-19 antigen testing devices
Federal

The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices.

Last Updated: Oct. 2, 2020
Date Published: Sep. 29, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, testing devices, antigen testing devices, minimum values of sensitivity for COVID-19 antigen testing devices
Federal

Coronavirus, COVID-19, pandemic, outbreak, testing, diagnosis, contact tracing, testing devices, point-of-care, POC, antigen, antibodies, molecular, FDA, non-laboratory use

Last Updated: Jul. 27, 2021
Date Published: Jun. 2, 2021
Organization: Health Canada
Formats: HTML
Keywords:  Coronavirus, COVID-19, pandémie, épidémie, test, diagnostic, recherche des contacts, dispositifs de test, point de service
Federal

Diagnosing and how we test, testing importance and contact tracing, increasing testing supply, test accuracy, testing for travellers, national overview of tests performed, roles and responsibilities, authorized testing devices, testing devices under review, access to and types of testing devices, testing and screening expert advisory panel, indutry advisory roundtable, and rapid tests for workplace screening.

Last Updated: Apr. 30, 2021
Date Published: Apr. 19, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, Coronavirus, testing, screening, contact tracing travellers, testing devices
Date modified: